Cargando…

Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases

A series of predictive scoring systems is available for stratifying the severity of conditions and assessing the prognosis in patients with HBV-related liver diseases. We show nine of the most popular serum biomarkers and their models (i.e., serum cystatin C, homocysteine, C-reactive protein, C-reac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, JianPing, Mao, WeiLin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391085/ https://www.ncbi.nlm.nih.gov/pubmed/32774512 http://dx.doi.org/10.1155/2020/2471252

Ejemplares similares

Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2019)

Mean Platelet Volume/Lymphocyte Ratio as a Prognostic Indicator for HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2020)

Differential proteomic analysis of plasma-derived exosomes as diagnostic biomarkers for chronic HBV-related liver disease
por: Ye, Bo, et al.
Publicado: (2022)

D-Dimer-to-Albumin Ratio: A Novel Indicator to Predict Poor Outcomes in Patients with HBV-Associated Decompensated Cirrhosis
por: Sun, Lin, et al.
Publicado: (2022)

Plasma D-dimer as a novel biomarker for predicting poor outcomes in HBV-related decompensated cirrhosis
por: Zhou, Jing, et al.
Publicado: (2019)

Identification of serum β-catenin as a biomarker in patients with HBV-related liver diseases
por: Duan, Liang, et al.
Publicado: (2018)

Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure
por: Zhang, Lili, et al.
Publicado: (2022)

Serum/Plasma MicroRNAs as Biomarkers for HBV-Related Hepatocellular Carcinoma in China
por: Yin, Wen, et al.
Publicado: (2015)

Neutrophil-to-Lymphocyte Ratio Predicts Early Mortality in Patients with HBV-Related Decompensated Cirrhosis
por: Zhang, Honggang, et al.
Publicado: (2016)

Identification of Serum CMTM2 as a Potential Biomarker for HBV-Related Disorders
por: Chen, Shu, et al.
Publicado: (2020)

Serum Sphingolipids Reflect the Severity of Chronic HBV Infection and Predict the Mortality of HBV-Acute-on-Chronic Liver Failure
por: Qu, Feng, et al.
Publicado: (2014)

Evaluation of the neutrophil‐to‐lymphocyte ratio, monocyte‐to‐lymphocyte ratio, and red cell distribution width for the prediction of prognosis of patients with hepatitis B virus‐related decompensated cirrhosis
por: Li, XinKe, et al.
Publicado: (2020)

The Potential of Serum Exosomal hsa_circ_0028861 as the Novel Diagnostic Biomarker of HBV-Derived Hepatocellular Cancer
por: Wang, Yuanxiao, et al.
Publicado: (2021)

Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease
por: Lu, Shi-Chun, et al.
Publicado: (2014)

Presence of Serum Antinuclear Antibodies Does Not Impact Outcomes in HBV-Related Acute-on-Chronic Liver Failure
por: Lin, Lin, et al.
Publicado: (2022)

HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles
por: Shata, Mohamed Tarek M., et al.
Publicado: (2019)

Plasma-Derived Exosomal SncRNA as a Promising Diagnostic Biomarker for Early Detection of HBV-Related Acute-on-Chronic Liver Failure
por: Xu, Wenli, et al.
Publicado: (2022)

Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC
por: Wei, Yanyan, et al.
Publicado: (2018)

Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases
por: Cai, Chunxian, et al.
Publicado: (2022)

Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma
por: Zhu, Hao-Tu, et al.
Publicado: (2016)

The different expression of caspase-1 in HBV-related liver disease and acts as a biomarker for acute-on-chronic liver failure
por: Zhang, Xiangying, et al.
Publicado: (2019)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Serum Ceruloplasmin Levels Correlate Negatively with Liver Fibrosis in Males with Chronic Hepatitis B: A New Noninvasive Model for Predicting Liver Fibrosis in HBV-Related Liver Disease
por: Zeng, Da-Wu, et al.
Publicado: (2013)

Derivation and Validation of a Nomogram for Predicting 90-Day Survival in Patients With HBV-Related Acute-on-Chronic Liver Failure
por: Chen, Jun-feng, et al.
Publicado: (2021)

Potentials of the elevated circulating miR-185 level as a biomarker for early diagnosis of HBV-related liver fibrosis
por: Li, Bin-bin, et al.
Publicado: (2016)

Decreased Serum Hepcidin Concentration Correlates with Brain Iron Deposition in Patients with HBV-Related Cirrhosis
por: Lin, Dong, et al.
Publicado: (2013)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

Risk factors and prognostic model for HBV-related subacute liver failure
por: Xu, Juan, et al.
Publicado: (2022)

Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma
por: De Crignis, Elisa, et al.
Publicado: (2021)

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
por: Lim, Young-Suk
Publicado: (2023)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Serum Testosterone Levels and Androgen Receptor CAG Polymorphism Correlate with Hepatitis B Virus (HBV)-Related Acute Liver Failure in Male HBV Carriers
por: Xu, Bao-Yan, et al.
Publicado: (2013)

Identification of Enolase 1 and Thrombospondin-1 as serum biomarkers in HBV hepatic fibrosis by proteomics
por: Zhang, Bin, et al.
Publicado: (2013)

The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylation
por: Li, Kang, et al.
Publicado: (2020)

Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure
por: Wu, Wei, et al.
Publicado: (2021)

Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
por: Furuta, Mayuko, et al.
Publicado: (2018)

Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma
por: Wu, Li-Ming, et al.
Publicado: (2010)

Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis
por: Li, Yuanyuan, et al.
Publicado: (2017)

Serum hepatitis B viral (HBV) DNA is a predictive biomarker for survival in non-small cell lung cancer patients with chronic HBV infection
por: Fu, Yumei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9dvsd1ujkuo1dsducu51kg56gd